May 10th 2024
Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Quality Measurement of Medication Monitoring in the Meaningful Use Era
Shifting from claims to integrated electronic health records to calculate quality metrics will improve reported quality attributable to data capture changes, not true quality improvements.
Read More